Licensed Fields of Use. (a) development and use of Licensed Patent Rights and Materials in combination with Licensee’s proprietary technology for the creation of a preventive Modified Vaccinia Ankara Virus-Virus Like Particle (MVA-VLP) vaccine primes and/or boosters against -“SARS-CoV-2.”
Appears in 2 contracts
Sources: Patent and Biological Materials License Agreement, Patent and Biological Materials License Agreement (GeoVax Labs, Inc.)